CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Alivus Life Sciences Ltd.

NSE : ALIVUSEQ BSE : 543322 ISIN CODE : INE03Q201024Industry : Pharmaceuticals

News

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Dec 2025 | 16:51 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Dec 2025 | 16:42 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 11 Dec 2025 | 16:36 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meet.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 03 Dec 2025 | 17:07 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 03 Dec 2025 | 17:01 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about the Schedule of meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 01 Dec 2025 | 17:00 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 01 Dec 2025 | 16:49 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 27 Nov 2025 | 20:59 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 27 Nov 2025 | 20:53 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meetingmore...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 14 Nov 2025 | 14:37 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Investor meetmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 14 Nov 2025 | 14:30 | Dion Global

    Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 13 Nov 2025 | 11:48 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Transcriptmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 13 Nov 2025 | 11:43 | Dion Global

    Enclosed please find Transcript of Earnings Call.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 07 Nov 2025 | 15:17 | Dion Global

    Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulati...more...

  • Alivus Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates 07 Nov 2025 | 15:08 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Weblink of Recording of Earnings Call Q2 FY2026.more...

  • Alivus Life Sciences - Investor Presentation 06 Nov 2025 | 19:28 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange about Investor Presentationmore...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation 06 Nov 2025 | 19:28 | Dion Global

    Enclosing herewith Investor Presentation - Q2 FY 2025-26.more...

  • Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release 06 Nov 2025 | 18:56 | Dion Global

    Press Release - Q2 FY 2026 Financialsmore...

  • Alivus Life Sciences - Press Release 06 Nov 2025 | 18:55 | Dion Global

    Alivus Life Sciences Limited has informed the Exchange regarding a press release dated November 06 2025 titled Press Release - Q2 FY2026 Financials. .more...

  • Alivus Life Sciences Q2 net profit up 36.41% at Rs 130.03 cr 06 Nov 2025 | 18:51 | Dion Global

    The company reported standalone net profit of Rs 130.03 crore for the quarter ended September 30 2025 as compared to Rs 95.32 crore in the s...more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex84679.86-0.63%
NSE Index25860.1-0.64%
BSE 1000 10971.43-0.65%
BSE 100LCTMC9522.27-0.61%
BSE Auto 61239.83-0.11%
BSE BasicMat7769.57-0.91%

Commodity

Gold1282210.61%
Silver1782361.53%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 90.39(0.02 %)
GBP/INR 121.06(0.23 %)
EUR/INR 106.08(0.45 %)
JPY/INR 0.58(0.20 %)
CAD/INR 65.60(0.00 %)
HKD/INR 11.62(0.02 %)